107 related articles for article (PubMed ID: 34968869)
1. Invasive phenotype in triple negative breast cancer is inhibited by blocking SIN3A-PF1 interaction through KLF9 mediated repression of ITGA6 and ITGB1.
Kadamb R; Leibovitch BA; Farias EF; Dahiya N; Suryawanshi H; Bansal N; Waxman S
Transl Oncol; 2022 Feb; 16():101320. PubMed ID: 34968869
[TBL] [Abstract][Full Text] [Related]
2. Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer.
Bansal N; Petrie K; Christova R; Chung CY; Leibovitch BA; Howell L; Gil V; Sbirkov Y; Lee E; Wexler J; Ariztia EV; Sharma R; Zhu J; Bernstein E; Zhou MM; Zelent A; Farias E; Waxman S
Oncotarget; 2015 Oct; 6(33):34087-105. PubMed ID: 26460951
[TBL] [Abstract][Full Text] [Related]
3. Targeted interference of SIN3A-TGIF1 function by SID decoy treatment inhibits Wnt signaling and invasion in triple negative breast cancer cells.
Kwon YJ; Leibovitch BA; Bansal N; Pereira L; Chung CY; Ariztia EV; Zelent A; Farias EF; Waxman S
Oncotarget; 2017 Oct; 8(51):88421-88436. PubMed ID: 29179446
[TBL] [Abstract][Full Text] [Related]
4. The Sin3A/MAD1 Complex, through Its PAH2 Domain, Acts as a Second Repressor of Retinoic Acid Receptor Beta Expression in Breast Cancer Cells.
Dahiya NR; Leibovitch BA; Kadamb R; Bansal N; Waxman S
Cells; 2022 Mar; 11(7):. PubMed ID: 35406744
[TBL] [Abstract][Full Text] [Related]
5. Blocking the PAH2 domain of Sin3A inhibits tumorigenesis and confers retinoid sensitivity in triple negative breast cancer.
Bansal N; Bosch A; Leibovitch B; Pereira L; Cubedo E; Yu J; Pierzchalski K; Jones JW; Fishel M; Kane M; Zelent A; Waxman S; Farias E
Oncotarget; 2016 Jul; 7(28):43689-43702. PubMed ID: 27286261
[TBL] [Abstract][Full Text] [Related]
6. Structural Insight into the Binding of TGIF1 to SIN3A PAH2 Domain through a C-Terminal Amphipathic Helix.
He X; Nie Y; Zhou H; Hu R; Li Y; He T; Zhu J; Yang Y; Liu M
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884456
[TBL] [Abstract][Full Text] [Related]
7. Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells.
Farias EF; Petrie K; Leibovitch B; Murtagh J; Chornet MB; Schenk T; Zelent A; Waxman S
Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11811-6. PubMed ID: 20547842
[TBL] [Abstract][Full Text] [Related]
8. Solution structure of the mSin3A PAH2-Pf1 SID1 complex: a Mad1/Mxd1-like interaction disrupted by MRG15 in the Rpd3S/Sin3S complex.
Kumar GS; Xie T; Zhang Y; Radhakrishnan I
J Mol Biol; 2011 May; 408(5):987-1000. PubMed ID: 21440557
[TBL] [Abstract][Full Text] [Related]
9. Pf1, a novel PHD zinc finger protein that links the TLE corepressor to the mSin3A-histone deacetylase complex.
Yochum GS; Ayer DE
Mol Cell Biol; 2001 Jul; 21(13):4110-8. PubMed ID: 11390640
[TBL] [Abstract][Full Text] [Related]
10. SIN3A and SIN3B differentially regulate breast cancer metastasis.
Lewis MJ; Liu J; Libby EF; Lee M; Crawford NP; Hurst DR
Oncotarget; 2016 Nov; 7(48):78713-78725. PubMed ID: 27780928
[TBL] [Abstract][Full Text] [Related]
11. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
12. Molecular Pathogenesis and Regulation of the
Hozaka Y; Seki N; Tanaka T; Asai S; Moriya S; Idichi T; Wada M; Tanoue K; Kawasaki Y; Mataki Y; Kurahara H; Ohtsuka T
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199886
[TBL] [Abstract][Full Text] [Related]
13. Sin3A recruits Tet1 to the PAH1 domain via a highly conserved Sin3-Interaction Domain.
Chandru A; Bate N; Vuister GW; Cowley SM
Sci Rep; 2018 Oct; 8(1):14689. PubMed ID: 30279502
[TBL] [Abstract][Full Text] [Related]
14. Kruppel-like factor-9 (KLF9) inhibits glioblastoma stemness through global transcription repression and integrin α6 inhibition.
Ying M; Tilghman J; Wei Y; Guerrero-Cazares H; Quinones-Hinojosa A; Ji H; Laterra J
J Biol Chem; 2014 Nov; 289(47):32742-56. PubMed ID: 25288800
[TBL] [Abstract][Full Text] [Related]
15. Differential binding of Sin3 interacting repressor domains to the PAH2 domain of Sin3A.
Pang YP; Kumar GA; Zhang JS; Urrutia R
FEBS Lett; 2003 Jul; 548(1-3):108-12. PubMed ID: 12885416
[TBL] [Abstract][Full Text] [Related]
16. Mad proteins contain a dominant transcription repression domain.
Ayer DE; Laherty CD; Lawrence QA; Armstrong AP; Eisenman RN
Mol Cell Biol; 1996 Oct; 16(10):5772-81. PubMed ID: 8816491
[TBL] [Abstract][Full Text] [Related]
17. Maximum growth and survival of estrogen receptor-alpha positive breast cancer cells requires the Sin3A transcriptional repressor.
Ellison-Zelski SJ; Alarid ET
Mol Cancer; 2010 Sep; 9():263. PubMed ID: 20920219
[TBL] [Abstract][Full Text] [Related]
18. The ErbB3 binding protein Ebp1 interacts with Sin3A to repress E2F1 and AR-mediated transcription.
Zhang Y; Akinmade D; Hamburger AW
Nucleic Acids Res; 2005; 33(18):6024-33. PubMed ID: 16254079
[TBL] [Abstract][Full Text] [Related]
19. The Chromatin-Associated Phf12 Protein Maintains Nucleolar Integrity and Prevents Premature Cellular Senescence.
Graveline R; Marcinkiewicz K; Choi S; Paquet M; Wurst W; Floss T; David G
Mol Cell Biol; 2017 Mar; 37(5):. PubMed ID: 27956701
[TBL] [Abstract][Full Text] [Related]
20. A 13-amino acid amphipathic alpha-helix is required for the functional interaction between the transcriptional repressor Mad1 and mSin3A.
Eilers AL; Billin AN; Liu J; Ayer DE
J Biol Chem; 1999 Nov; 274(46):32750-6. PubMed ID: 10551834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
